Diabetic Mellitus Patients Glucose Range Awareness After Experiencing a New Blood Glucose Meter Feature


A single visit & single arm study in 80 subjects with diabetes to determine if a short educational experience with a new blood glucose meter feature improves the ability of each subject to better classify glucose results into acceptable glucose ranges.

Study Type

  • Study Type: Interventional
  • Study Design
    • Allocation: N/A
    • Intervention Model: Single Group Assignment
    • Primary Purpose: Basic Science
    • Masking: None (Open Label)
  • Study Primary Completion Date: August 2015


  • Behavioral: Education with new meter feature.
    • The blood glucose meter has default settings for the colour range indicator which can be customized by the subjects and/or their healthcare professional. This colour range indicator will be presented to the subjects as a computer simulation to show subjects a range of typical blood glucose values and how this new feature would classify these results as being low (blue), in-range (green) or high (red).

Arms, Groups and Cohorts

  • Experimental: Education with new meter feature.
    • Subjects experience a computer stimulation of a new meter feature ( colour range indicator) to help subjects interpret whether blood glucose results are low, in-range or high based on accepted guidance.

Clinical Trial Outcome Measures

Primary Measures

  • Success rate to categorize blood glucose values into accepted ranges.
    • Time Frame: On average within 30 mins post intervention.

Secondary Measures

  • Actual time taken to categorize blood glucose values into accepted ranges on the questionnaire provided.
    • Time Frame: On average within 30 mins post intervention.

Participating in This Clinical Trial

Inclusion Criteria

  • Diagnosed with Type 1 diabetes Mellitus (T1DM) or Type 2 diabetes Mellitus (T2DM) for ≥ 3 months
  • Currently performing self monitoring of blood glucose (SMBG) at home
  • Aged ≥16 years

Exclusion Criteria

  • Previous use of any blood glucose meter with the colour range indicator feature to be evaluated in this study.

Gender Eligibility: All

Minimum Age: 16 Years

Maximum Age: N/A

Are Healthy Volunteers Accepted: No

Investigator Details

  • Lead Sponsor
    • LifeScan
  • Provider of Information About this Clinical Study
    • Sponsor
  • Overall Official(s)
    • Mike Grady, Phd, Study Director, LifeScan

Clinical trials entries are delivered from the US National Institutes of Health and are not reviewed separately by this site. Please see the identifier information above for retrieving further details from the government database.

At TrialBulletin.com, we keep tabs on over 200,000 clinical trials in the US and abroad, using medical data supplied directly by the US National Institutes of Health. Please see the About and Contact page for details.